MESOBLAST LIMITED
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2M | $5.9M | $7.5M | $10.2M | $7.4M | $32.2M | $16.7M | $17.3M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-80.1M | $-67.5M | $-62.7M | $-74.7M | $-83.7M | $-72.6M | $-87.1M | $-64.1M |
| Operating Margin | -465.5% | -1,143.5% | -835.3% | -731.4% | -1,125.8% | -225.9% | -520.6% | -369.9% |
| Interest Expense | $21.8M | $20.7M | $19.4M | $16.9M | $15.9M | $14.7M | $11.7M | $1.8M |
| Pretax Income | $-101.8M | $-88.1M | $-82.1M | $-91.6M | $-99.6M | $-87.4M | $-98.8M | $-66.0M |
| Income Tax Expense | $330.0K | $-191.0K | $-212.0K | $-239.0K | $-819.0K | $-9.4M | $-9.0M | $-30.7M |
| Net Income | $-102.1M | $-88.0M | $-81.9M | $-91.3M | $-98.8M | $-77.9M | $-89.8M | $-35.3M |
| Net Margin | -593.9% | -1,490.3% | -1,091.7% | -894.6% | -1,329.2% | -242.4% | -537.0% | -203.5% |
| EPS (Basic) | $-0.08 | $-0.09 | $-0.11 | $-0.13 | $-0.16 | $-0.15 | $-0.18 | $-0.08 |
| EPS (Diluted) | $-0.08 | $-0.09 | $-0.11 | $-0.13 | $-0.16 | $-0.15 | $-0.18 | $-0.08 |
| Shares Outstanding (Basic) | 1.28B | 1.14B | 814.2M | 650.5M | 648.7M | 583.9M | 498.6M | 482.6M |
| Shares Outstanding (Diluted) | 1.28B | 1.14B | 814.2M | 650.5M | 648.7M | 583.9M | 498.6M | 482.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |